- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. European Urology. 2017 In Process GET IT
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Academic Article GET IT
- The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review. European Urology. 2014 Information Resource GET IT
- Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. European Urology. 2014 Information Resource GET IT
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial.
The Lancet. Oncology.
Times cited: 82
High-risk prostate cancer: from definition to contemporary management.
Times cited: 76
- Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. European Urology. 2011 Information Resource GET IT
- Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases.
Times cited: 1
Pelvic lymph node dissection in prostate cancer.
Times cited: 271
- Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease. Cancer. 1998 Information Resource GET IT